Trademark: 97021075
Word
LOGIKINE
Status
Pending
Status Code
641
Status Date
Friday, March 15, 2024
Serial Number
97021075
Mark Type
4000
Filing Date
Friday, September 10, 2021
Published for Opposition
Tuesday, February 28, 2023

Trademark Owner History
Suzhou Fuse Biosciences Limited - Owner At Publication

Classifications
5 Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; diagnostic preparations and substances for medical purposes; immunotherapies and therapeutic agents in the field of locoregionally active cytokines for medical purposes; immunotherapies, therapeutic agents, diagnostic preparations, and diagnostic substances in the field of oncology for medical purposes
42 Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the fields of immunocytokines; providing medical and scientific research information in the fields of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating to therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing scientific research consultation in the field of antibody selection and use

Trademark Events
Mar 15, 2024
Notification Of Non-Final Action E-Mailed
Mar 15, 2024
Non-Final Action E-Mailed
Mar 15, 2024
Non-Final Action Written
Mar 15, 2024
Previous Allowance Count Withdrawn
Mar 13, 2024
Case Returned To Examination
Mar 13, 2024
Notice Of Allowance Cancelled
Feb 21, 2024
Jurisdiction Restored To Examining Attorney
Feb 21, 2024
Petition To Director - Change Basis - Granted
Feb 20, 2024
Assigned To Petition Staff
Jan 30, 2024
Teas Petition To Amend Basis Received
Dec 13, 2023
Teas Change Of Correspondence Received
Dec 13, 2023
Teas Change Of Domestic Representatives Address
Dec 13, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 13, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 14, 2023
Notice Of Approval Of Extension Request E-Mailed
Oct 12, 2023
Sou Extension 1 Granted
Oct 12, 2023
Sou Extension 1 Filed
Oct 12, 2023
Sou Teas Extension Received
Apr 25, 2023
Noa E-Mailed - Sou Required From Applicant
Feb 28, 2023
Official Gazette Publication Confirmation E-Mailed
Feb 28, 2023
Published For Opposition
Feb 8, 2023
Notification Of Notice Of Publication E-Mailed
Jan 20, 2023
Approved For Pub - Principal Register
Dec 23, 2022
Teas/Email Correspondence Entered
Dec 22, 2022
Correspondence Received In Law Office
Dec 22, 2022
Teas Response To Office Action Received
Jun 22, 2022
Notification Of Non-Final Action E-Mailed
Jun 22, 2022
Non-Final Action E-Mailed
Jun 22, 2022
Non-Final Action Written
Jun 15, 2022
Assigned To Examiner
Oct 19, 2021
New Application Office Supplied Data Entered
Sep 14, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24